Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA-23b-5p (miR-23b-5p) is a small, non-coding RNA that regulates gene expression post-transcriptionally, influencing mRNA stability and translation[2][4]. miR-23b-5p plays complex roles in biological processes including cell proliferation, differentiation, apoptosis, immune function, and adipocyte metabolism. It has been shown to act as either a tumor suppressor or oncogene depending on cellular context[4]. In brown adipose tissue, miR-23b-5p functions as a negative regulator of thermogenic gene programs, impairing mitochondrial content and oxidative capacity when overexpressed[1]. Disease associations include various cancers, autoimmune diseases, and cardiovascular pathology, and it may serve as a non-invasive biomarker (e.g., in IPMN via saliva testing)[2][4]. Its broad impact on gene networks makes it a candidate therapeutic target and biomarker, but also presents challenges for therapeutic specificity and safety[4][1].
Post-transcriptional inhibition of target mRNAs via binding to 3' UTRs
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA-23b-5p (miR-23b-5p).